TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
DXR

Daxor Corporation

Healthcare · Medical Instruments & Supplies

11.50$ +1.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement DXR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – -155.1% – – – – +8.4% +448.2% -93.8% -76.4%
– -37.6% -12.1% -29.9% +78.7% +41.0% +15.2% +77.9% +8.5% -83.7% – –
– – – -164.9% – – – – +8.4% +445.3% -93.8% -91.1%
– – – – – – +121.4% +193.5% +704.9% -99.9% – –
– -5.0% -19.4% -59.1% +106.1% +49.6% +54.5% +67.0% +9.5% -71.7% -4.3% +11.2%
– -3.6% -15.8% -44.6% +47.2% +27.0% +92.9% +46.1% +5.5% -17.1% +69.8% -664.2%
– – – -177.8% – – – – +10.6% -93.7% +88.5% +1,378.2%
– -31.7% -76.8% +95.5% +66.2% +18.3% -94.1% +133.3% +269.6% -32.2% +73.3% -81.2%
– – – -182.8% – – – – +9.1% -94.6% +91.1% +1,609.7%
– – -99.1% +112.0% -1,451.1% – – – – – – –
– – – -185.2% – – – – +9.1% -94.6% +91.1% +1,609.7%
– – – -177.8% – – – – +10.6% -93.7% +524.2% +346.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?